Navigation Links
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Date:7/1/2008

nemia with excess blasts, refractory anemia with excess blasts in transformation, chronic myelomonocytic leukemia), and Intermediate-1, Intermediate-2, and High-Risk International Prognostic Scoring System (IPSS) groups.

Ongoing Clinical Studies

Eisai Inc. is conducting a series of clinical trials in the service of Dacogen's development to further understand the optimal treatment for MDS and related conditions. Currently, more than 30 clinical studies of Dacogen are being conducted, including a Phase 3 pivotal trial to evaluate Dacogen in patients with AML.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2007 (year ended March 31, 2008) sales of approximately $3 billion, including the results of the acquisition of MGI PHARMA. For more information about Eisai, please visit http://www.eisai.com.

Forward-Looking Statements

This news release contains certain "for
'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session
2. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
3. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
4. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
5. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
6. SuperGens DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine
7. Data Show SuperGens MP-470 is Safe in Humans
8. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models
9. SuperGens PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models
10. SuperGens JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation
11. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)... Day 2008 focuses on the need to protect the eyesi.../ -- Of the 45 million people worldwide who,are bl...s of them could,have avoided their blindness if th...ew the Multimedia News Release, go to:, http://www...ld,s leader in eye care products and equipment, is...
(Date:10/9/2008)...October 9 /- Diamyd Medical... journal, the New England Journal,of Medicine, has...y,s study,of the Diamyd(R) diabetes vaccine for ty...i-bin/prnh/20080314/297194 ), The article is now...nejm.org ) and will be in print on October 30. It ...
(Date:10/8/2008)...rt Institute Pioneers Research That May Offer New ...- Nationally, over 3,000 people are,w... life. Sadly, only half,of those will receive a tr...t Institute (AHI) is paving the way for how to tre...iew the Multimedia News Release, go to:, http://ww...
(Date:10/8/2008)...ngs Confirm Potency of Poly-ICR as Vaccine Adjuvan...enta Biopharmaceuticals,Corporation (TSX: NVN) tod...s using its proprietary Toll-like Receptor 3 agoni... Vaccine Congress 2008 in Lyon, France.,Study resu...djuvant,targeting the Toll-like Receptor 3 (TLR3) ...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 1NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 2NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 3NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 4NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 5NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 6NetSuite Partners Introduce New Vertical Versions of NetSuite and Horizontal Extensions to Core NetSuite Functionality 4620 7The Scooter Store to Provide Power Mobility Equipment to HealthPlus of Michigan Patients 4616 1The Scooter Store to Provide Power Mobility Equipment to HealthPlus of Michigan Patients 4616 2The Scooter Store to Provide Power Mobility Equipment to HealthPlus of Michigan Patients 4616 3Bayer Issues Additional Guidance to Physicians on Trasylol 28R 29 663 1Bayer Issues Additional Guidance to Physicians on Trasylol 28R 29 663 2Bayer Issues Additional Guidance to Physicians on Trasylol 28R 29 663 3Bayer Issues Additional Guidance to Physicians on Trasylol 28R 29 663 4Bayer Issues Additional Guidance to Physicians on Trasylol 28R 29 663 5Brain Region Tied to Amphetamine Addiction 4613 1Brain Region Tied to Amphetamine Addiction 4613 2
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
(Date:10/11/2008)... MegaFest International Transcends Cultural D...wswire/ -- South African and,international audienc...national,s electrifying gathering, which for the f...ica., (Photo: http://www.newscom.com/cgi-bin/prn...y festival kicked off with performances by,South A...
(Date:10/10/2008)...likely to develop some form of disease by 20 years... Oct. 10 (HealthDay News) -- Liver transplant pati...neral population, say researchers in Finland. ,... Liver Transplantation , researchers investigated...splant recipients from Helsinki University Central...
(Date:10/10/2008)...Lilly and Company committed to helping people addr...re-FirstCall/ -- In these troubling,economic times...priority,and may feel that they don,t have the mon...ccording to a survey by the National Association o...t 2008:(1), -- Twenty-two percent of Americans sa...
(Date:10/10/2008)...FORD, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Hol...manufacturer and supplier of premium,diagnostics, ...cated to,serving the healthcare needs of women, to...and fiscal 2008 operating results on Tuesday, Nove...ith the release, management will,host a conference...
Breaking Medicine News(10 mins):Health News:Bishop T.D. Jakes Electrifies South Africa 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2
...ty British cruise vessel, Funchal that has been ar...off the West Australian coast, and will host the m...ngers on board have been infected by a contagious ...municable Disease Control, Dr. Paul Van Buynder sa...
...dex as a tool and indicator of diet is being quest...s. High-GI foods, like white bread and potatoes, t...ome studies have suggested that diets heavy in suc...eight gain, diabetes and heart disease. Still, a d...
...radesh, which has been facing the death of a large...ted the authorities, who in turn has started inves... flu. Suraj Damor, the district magistrate of Burh...in poultry farms at Ichhapur village. Other repor...
...l LWT - Food Science and Technology say that consu...imer’s disease. // Ho Jin Heo and Chang Yong Lee ...nd that red cabbage extract could significantly re...deposits that scientists believe attribute to the ...
Other Medicine News:Health News:Bird Flu Fear Grips Madhya Pradesh 2
Barraquer needle holder, curved, delicate.
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Yasargil Spring Hool with Bulldog Clamp, Galea hook.
Extremely fine straight.
Medicine Products: